Literature DB >> 15659405

CK2 phosphorylates SSRP1 and inhibits its DNA-binding activity.

Yanping Li1, David M Keller, John D Scott, Hua Lu.   

Abstract

We have previously shown that CK2 associates with the human high-mobility group protein SSRP1 and that this association increases in response to UV irradiation. CK2 also phosphorylates SSRP1 in vitro. Here we extend this work by investigating CK2 regulation of SSRP1 function through phosphorylation. Phosphorylation of SSRP1 by CK2 inhibited the nonspecific DNA-binding activity of SSRP1 and FACT (facilitating chromatin-mediated transcription) complex in vitro. Using a serine/threonine-scanning Auto-spot peptide array coupled with a filter-based kinase assay with synthetic peptides as substrates, we identified serines 510, 657, and 688 as phosphorylation targets of CK2 in vitro. Mutagenesis of the three serines revealed that serine 510 was more important for the regulation of SSRP1 DNA-binding activity. Furthermore, we found that SSRP1 was phosphorylated in cells in response to UV (but not gamma) irradiation. These results suggest that CK2 regulates the DNA-binding ability of SSRP1 and that this regulation may be responsive to specific cell stresses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15659405      PMCID: PMC3923407          DOI: 10.1074/jbc.M413944200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Protein kinase CK2 differentially phosphorylates maize chromosomal high mobility group B (HMGB) proteins modulating their stability and DNA interactions.

Authors:  Christian Stemmer; Andrea Schwander; Guy Bauw; Peter Fojan; Klaus D Grasser
Journal:  J Biol Chem       Date:  2001-11-01       Impact factor: 5.157

2.  p53 serine 392 phosphorylation increases after UV through induction of the assembly of the CK2.hSPT16.SSRP1 complex.

Authors:  David M Keller; Hua Lu
Journal:  J Biol Chem       Date:  2002-10-21       Impact factor: 5.157

3.  Protein kinase CK2 phosphorylates the high mobility group domain protein SSRP1, inducing the recognition of UV-damaged DNA.

Authors:  Nicholas M Krohn; Christian Stemmer; Peter Fojan; Rudi Grimm; Klaus D Grasser
Journal:  J Biol Chem       Date:  2003-02-04       Impact factor: 5.157

4.  A bipartite yeast SSRP1 analog comprised of Pob3 and Nhp6 proteins modulates transcription.

Authors:  N K Brewster; G C Johnston; R A Singer
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

5.  The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins.

Authors:  G Orphanides; W H Wu; W S Lane; M Hampsey; D Reinberg
Journal:  Nature       Date:  1999-07-15       Impact factor: 49.962

6.  SSRP1 functions as a co-activator of the transcriptional activator p63.

Authors:  Shelya X Zeng; Mu-Shui Dai; David M Keller; Hua Lu
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

7.  POB3 is required for both transcription and replication in the yeast Saccharomyces cerevisiae.

Authors:  M B Schlesinger; T Formosa
Journal:  Genetics       Date:  2000-08       Impact factor: 4.562

8.  Folding pathway mediated by an intramolecular chaperone. A functional peptide chaperone designed using sequence databases.

Authors:  Yukihiro Yabuta; Ezhilkani Subbian; Catherine Oiry; Ujwal Shinde
Journal:  J Biol Chem       Date:  2003-02-11       Impact factor: 5.157

9.  Interaction of FACT, SSRP1, and the high mobility group (HMG) domain of SSRP1 with DNA damaged by the anticancer drug cisplatin.

Authors:  A T Yarnell; S Oh; D Reinberg; S J Lippard
Journal:  J Biol Chem       Date:  2001-05-08       Impact factor: 5.157

10.  Disruption of the regulatory beta subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality.

Authors:  Thierry Buchou; Muriel Vernet; Olivier Blond; Hans H Jensen; Hervé Pointu; Birgitte B Olsen; Claude Cochet; Olaf-Georg Issinger; Brigitte Boldyreff
Journal:  Mol Cell Biol       Date:  2003-02       Impact factor: 4.272

View more
  26 in total

1.  CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules.

Authors:  Matthew S Brown; Oumou T Diallo; Michael Hu; Reza Ehsanian; Xinping Yang; Pattatheyil Arun; Hai Lu; Vicci Korman; Gretchen Unger; Khalil Ahmed; Carter Van Waes; Zhong Chen
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

2.  Facilitates chromatin transcription complex is an "accelerator" of tumor transformation and potential marker and target of aggressive cancers.

Authors:  Henry Garcia; Jeffrey C Miecznikowski; Alfiya Safina; Mairead Commane; Anja Ruusulehto; Sami Kilpinen; Robert W Leach; Kristopher Attwood; Yan Li; Seamus Degan; Angela R Omilian; Olga Guryanova; Olympia Papantonopoulou; Jianmin Wang; Michael Buck; Song Liu; Carl Morrison; Katerina V Gurova
Journal:  Cell Rep       Date:  2013-07-03       Impact factor: 9.423

3.  Differential regulation of mitogen- and stress-activated protein kinase-1 and -2 (MSK1 and MSK2) by CK2 following UV radiation.

Authors:  Kellie A Jacks; C Anne Koch
Journal:  J Biol Chem       Date:  2009-11-20       Impact factor: 5.157

Review 4.  Deciphering enzyme function using peptide arrays.

Authors:  Alexandra Thiele; Gabriele I Stangl; Mike Schutkowski
Journal:  Mol Biotechnol       Date:  2011-11       Impact factor: 2.695

5.  Drosophila MCRS2 associates with RNA polymerase II complexes to regulate transcription.

Authors:  Ditte Skovaa Andersen; Sunil Jayaramaiah Raja; Julien Colombani; Rachael Louise Shaw; Paul Francis Langton; Asifa Akhtar; Nicolas Tapon
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

6.  Proteomic characterization of the nucleolar linker histone H1 interaction network.

Authors:  Heather J Szerlong; Jacob A Herman; Christine M Krause; Jennifer G DeLuca; Arthur Skoultchi; Quinton A Winger; Jessica E Prenni; Jeffrey C Hansen
Journal:  J Mol Biol       Date:  2015-01-10       Impact factor: 5.469

7.  Histone Chaperone FACT and Curaxins: Effects on Genome Structure and Function.

Authors:  Han-Wen Chang; Ekaterina V Nizovtseva; Sergey V Razin; Tim Formosa; Katerina V Gurova; Vasily M Studitsky
Journal:  J Cancer Metastasis Treat       Date:  2019-11-29

8.  Phosphorylated intrinsically disordered region of FACT masks its nucleosomal DNA binding elements.

Authors:  Yasuo Tsunaka; Junko Toga; Hiroto Yamaguchi; Shin-ichi Tate; Susumu Hirose; Kosuke Morikawa
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

9.  FACT facilitates chromatin transcription by RNA polymerases I and III.

Authors:  Joanna L Birch; Bertrand C-M Tan; Kostya I Panov; Tatiana B Panova; Jens S Andersen; Tom A Owen-Hughes; Jackie Russell; Sheng-Chung Lee; Joost C B M Zomerdijk
Journal:  EMBO J       Date:  2009-02-12       Impact factor: 11.598

10.  A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047.

Authors:  Wen-Lin Kuo; Debopriya Das; Safiyyah Ziyad; Sanchita Bhattacharya; William J Gibb; Laura M Heiser; Anguraj Sadanandam; Gerald V Fontenay; Zhi Hu; Nicholas J Wang; Nora Bayani; Heidi S Feiler; Richard M Neve; Andrew J Wyrobek; Paul T Spellman; Laurence J Marton; Joe W Gray
Journal:  BMC Med       Date:  2009-12-14       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.